Patents by Inventor Rebecca Sandlin

Rebecca Sandlin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230365914
    Abstract: Methods of bulk cryopreservation of C. parvum oocysts by vitrification using high aspect ratio cryopreservation devices are disclosed. Cryopreserved oocysts exhibit high viability, maintain infectivity in vitro, and are infectious to interferon-? knockout mice. The course of the infection is comparable to that observed with unfrozen oocysts.
    Type: Application
    Filed: March 19, 2021
    Publication date: November 16, 2023
    Inventors: Derin Sevenler, Rebecca Sandlin, Mehmet Toner, Giovanni Widmer, Saul Tzipori, Justyna Jaskiewicz
  • Publication number: 20230270103
    Abstract: Hydrogel beads having tunable rates of loading and unloading of cryoprotective agents are provided herein. Such hydrogel beads can be dispersed throughout a cell suspension to enable loading and unloading of cryoprotective agents from cells in a gradual and distributed manner that protects the cells from osmotic damage. Lymphocyte viability after cryopreservation is significantly greater when cryoprotective agents are loaded and unloaded using hydrogel beads compared to conventional media exchange methods.
    Type: Application
    Filed: July 19, 2021
    Publication date: August 31, 2023
    Inventors: Derin Sevenler, Rebecca Sandlin, Mehmet Toner
  • Patent number: 11612163
    Abstract: Methods for stabilizing blood samples, e.g., clinical blood samples, for storage or transportation before use.
    Type: Grant
    Filed: July 23, 2020
    Date of Patent: March 28, 2023
    Assignee: The General Hospital Corporation
    Inventors: Rebecca Sandlin, Keith Wong, Shannon Tessier, Mehmet Toner, Shannon Stott
  • Publication number: 20220307066
    Abstract: The disclosure addresses methods, compositions, and kits used to detect or quantify polymerase inhibitors in biological samples. The polymerase inhibitors can be therapeutic agents, or metabolites thereof, that have been administered to a subject as part of, for example, antiretroviral therapy (ART) or pre-exposure prophylaxis (PrEP) to address potential infections by, e.g., retroviruses such as HIV and other viruses reliant on reverse transcription. These methods, compositions, and kits can be applied to monitor a subject's compliance with the indicated therapies and can inform potential adjustments to the therapies.
    Type: Application
    Filed: June 12, 2020
    Publication date: September 29, 2022
    Applicants: University of Washington, The General Hospital Corporation
    Inventors: Ayokunle Olanrewaju, Paul Drain, Jonathan Posner, Derin Sevenler, Benjamin Sullivan, Andrew Bender, Jane Zhang, Rebecca Sandlin
  • Publication number: 20220104482
    Abstract: Compositions, methods and kits are described for stabilizing cells and biological samples, allowing for storage and transportation of stabilized cells and biological samples. Cells can be stabilized in whole blood or fractionated blood. Isolated cells can also be stabilized.
    Type: Application
    Filed: February 7, 2020
    Publication date: April 7, 2022
    Inventors: Mehmet Toner, Rebecca Sandlin, Anne Knecht, Ho Ki Wong, Shannon N. Tessier, Shannon Stott
  • Publication number: 20210007348
    Abstract: Methods for stabilizing blood samples, e.g., clinical blood samples, for storage or transportation before use.
    Type: Application
    Filed: July 23, 2020
    Publication date: January 14, 2021
    Inventors: Rebecca Sandlin, Keith Wong, Shannon Tessier, Mehmet Toner, Shannon Stott
  • Patent number: 10750739
    Abstract: Methods for stabilizing blood samples, e.g., clinical blood samples, for storage or transportation before use. Exemplary applications include but are not limited to enrichment of leukocyte subtypes such as T-cells or neutrophils for cytokine and immuno-assays; isolation of progenitor cells from cord blood or peripheral blood for transplantation; isolation of fetal cells from the maternal blood for diagnosis; and sorting of circulating tumor cells for cancer detection and therapy.
    Type: Grant
    Filed: July 31, 2015
    Date of Patent: August 25, 2020
    Assignee: The General Hospital Corporation
    Inventors: Rebecca Sandlin, Keith Wong, Shannon Tessier, Mehmet Toner, Shannon Stott
  • Publication number: 20170223949
    Abstract: Methods for stabilizing blood samples, e.g., clinical blood samples, for storage or transportation before use. Exemplary applications include but are not limited to enrichment of leukocyte subtypes such as T-cells or neutrophils for cytokine and immuno-assays; isolation of progenitor cells from cord blood or peripheral blood for transplantation; isolation of fetal cells from the maternal blood for diagnosis; and sorting of circulating tumor cells for cancer detection and therapy.
    Type: Application
    Filed: July 31, 2015
    Publication date: August 10, 2017
    Inventors: Rebecca Sandlin, Keith Wong, Shannon Tessier, Mehmet Toner